nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—XDH—Azathioprine—Crohn's disease	0.26	0.357	CbGbCtD
Daunorubicin—XDH—Mercaptopurine—Crohn's disease	0.26	0.357	CbGbCtD
Daunorubicin—ABCC2—Sulfasalazine—Crohn's disease	0.0741	0.102	CbGbCtD
Daunorubicin—ABCG2—Sulfasalazine—Crohn's disease	0.067	0.0918	CbGbCtD
Daunorubicin—CYP3A5—Sulfasalazine—Crohn's disease	0.0371	0.0509	CbGbCtD
Daunorubicin—ABCB1—Prednisone—Crohn's disease	0.0193	0.0265	CbGbCtD
Daunorubicin—ABCB11—bile—Crohn's disease	0.0154	0.208	CbGeAlD
Daunorubicin—CYP3A4—Prednisone—Crohn's disease	0.0116	0.0159	CbGbCtD
Daunorubicin—ABCC2—bile—Crohn's disease	0.00785	0.106	CbGeAlD
Daunorubicin—Hepatic impairment—Mesalazine—Crohn's disease	0.00559	0.037	CcSEcCtD
Daunorubicin—Alopecia reversible—Mesalazine—Crohn's disease	0.0045	0.0298	CcSEcCtD
Daunorubicin—Myocarditis—Mesalazine—Crohn's disease	0.00418	0.0277	CcSEcCtD
Daunorubicin—Myelosuppression—Mercaptopurine—Crohn's disease	0.00401	0.0266	CcSEcCtD
Daunorubicin—Secondary infection—Azathioprine—Crohn's disease	0.00382	0.0253	CcSEcCtD
Daunorubicin—Skin hyperpigmentation—Mercaptopurine—Crohn's disease	0.00316	0.021	CcSEcCtD
Daunorubicin—Meningitis—Azathioprine—Crohn's disease	0.00289	0.0192	CcSEcCtD
Daunorubicin—Bone marrow depression—Mercaptopurine—Crohn's disease	0.00279	0.0185	CcSEcCtD
Daunorubicin—Rectal tenesmus—Mesalazine—Crohn's disease	0.00274	0.0182	CcSEcCtD
Daunorubicin—NR5A1—lymphoid tissue—Crohn's disease	0.00271	0.0366	CbGeAlD
Daunorubicin—Sinus tachycardia—Mesalazine—Crohn's disease	0.00254	0.0168	CcSEcCtD
Daunorubicin—Pericardial effusion—Mesalazine—Crohn's disease	0.00249	0.0165	CcSEcCtD
Daunorubicin—Myelosuppression—Azathioprine—Crohn's disease	0.00239	0.0158	CcSEcCtD
Daunorubicin—Pericarditis—Mesalazine—Crohn's disease	0.00236	0.0156	CcSEcCtD
Daunorubicin—YWHAG—smooth muscle tissue—Crohn's disease	0.00224	0.0302	CbGeAlD
Daunorubicin—Lung infiltration—Mesalazine—Crohn's disease	0.00218	0.0144	CcSEcCtD
Daunorubicin—Proctalgia—Mesalazine—Crohn's disease	0.00218	0.0144	CcSEcCtD
Daunorubicin—TOP2B—smooth muscle tissue—Crohn's disease	0.00216	0.0291	CbGeAlD
Daunorubicin—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00203	0.0134	CcSEcCtD
Daunorubicin—YWHAG—mammalian vulva—Crohn's disease	0.00202	0.0272	CbGeAlD
Daunorubicin—Ulcer—Mercaptopurine—Crohn's disease	0.00199	0.0132	CcSEcCtD
Daunorubicin—XDH—mammalian vulva—Crohn's disease	0.00197	0.0266	CbGeAlD
Daunorubicin—TOP2B—mammalian vulva—Crohn's disease	0.00195	0.0262	CbGeAlD
Daunorubicin—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00192	0.0127	CcSEcCtD
Daunorubicin—Anorectal discomfort—Mesalazine—Crohn's disease	0.00187	0.0124	CcSEcCtD
Daunorubicin—Local reaction—Mesalazine—Crohn's disease	0.00184	0.0122	CcSEcCtD
Daunorubicin—YWHAG—lymphoid tissue—Crohn's disease	0.00179	0.0242	CbGeAlD
Daunorubicin—YWHAG—digestive system—Crohn's disease	0.00177	0.0239	CbGeAlD
Daunorubicin—Haemorrhoids—Mesalazine—Crohn's disease	0.00174	0.0115	CcSEcCtD
Daunorubicin—TOP2B—lymphoid tissue—Crohn's disease	0.00173	0.0233	CbGeAlD
Daunorubicin—XDH—digestive system—Crohn's disease	0.00173	0.0233	CbGeAlD
Daunorubicin—TOP2B—digestive system—Crohn's disease	0.00171	0.023	CbGeAlD
Daunorubicin—ABCB11—digestive system—Crohn's disease	0.00169	0.0227	CbGeAlD
Daunorubicin—Bone marrow depression—Azathioprine—Crohn's disease	0.00166	0.011	CcSEcCtD
Daunorubicin—Nail disorder—Mesalazine—Crohn's disease	0.00157	0.0104	CcSEcCtD
Daunorubicin—POR—mammalian vulva—Crohn's disease	0.00153	0.0207	CbGeAlD
Daunorubicin—Bone marrow depression—Mesalazine—Crohn's disease	0.00151	0.01	CcSEcCtD
Daunorubicin—Liver disorder—Mesalazine—Crohn's disease	0.0015	0.00992	CcSEcCtD
Daunorubicin—TOP2A—Methyldopa—Mesalazine—Crohn's disease	0.00144	0.766	CbGdCrCtD
Daunorubicin—TOP2A—mammalian vulva—Crohn's disease	0.00143	0.0193	CbGeAlD
Daunorubicin—Meningitis—Prednisone—Crohn's disease	0.00139	0.00923	CcSEcCtD
Daunorubicin—Rigors—Azathioprine—Crohn's disease	0.00137	0.0091	CcSEcCtD
Daunorubicin—SLC22A2—digestive system—Crohn's disease	0.00135	0.0183	CbGeAlD
Daunorubicin—Opportunistic infection—Prednisone—Crohn's disease	0.00134	0.00889	CcSEcCtD
Daunorubicin—CYP1A1—mouth—Crohn's disease	0.00134	0.0181	CbGeAlD
Daunorubicin—ABCC10—mammalian vulva—Crohn's disease	0.00122	0.0164	CbGeAlD
Daunorubicin—Pancytopenia—Mercaptopurine—Crohn's disease	0.00112	0.00743	CcSEcCtD
Daunorubicin—ABCC10—lymphoid tissue—Crohn's disease	0.00108	0.0146	CbGeAlD
Daunorubicin—ABCC10—digestive system—Crohn's disease	0.00107	0.0144	CbGeAlD
Daunorubicin—CYP1B1—smooth muscle tissue—Crohn's disease	0.00106	0.0143	CbGeAlD
Daunorubicin—CYP1B1—skin of body—Crohn's disease	0.00105	0.0142	CbGeAlD
Daunorubicin—Stomatitis—Mercaptopurine—Crohn's disease	0.00103	0.0068	CcSEcCtD
Daunorubicin—YWHAG—lymph node—Crohn's disease	0.00101	0.0136	CbGeAlD
Daunorubicin—Melaena—Mesalazine—Crohn's disease	0.000998	0.00661	CcSEcCtD
Daunorubicin—Influenza like illness—Mesalazine—Crohn's disease	0.000992	0.00657	CcSEcCtD
Daunorubicin—TOP2B—lymph node—Crohn's disease	0.000975	0.0131	CbGeAlD
Daunorubicin—Neuropathy—Mesalazine—Crohn's disease	0.000959	0.00635	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000931	0.00617	CcSEcCtD
Daunorubicin—Febrile neutropenia—Prednisone—Crohn's disease	0.000898	0.00595	CcSEcCtD
Daunorubicin—Hypertonia—Mesalazine—Crohn's disease	0.000895	0.00593	CcSEcCtD
Daunorubicin—Ear pain—Mesalazine—Crohn's disease	0.000869	0.00576	CcSEcCtD
Daunorubicin—Lymphadenopathy—Mesalazine—Crohn's disease	0.000869	0.00576	CcSEcCtD
Daunorubicin—ABCC1—mammalian vulva—Crohn's disease	0.000861	0.0116	CbGeAlD
Daunorubicin—ABCC2—digestive system—Crohn's disease	0.000858	0.0116	CbGeAlD
Daunorubicin—CYP1B1—lymphoid tissue—Crohn's disease	0.00085	0.0115	CbGeAlD
Daunorubicin—CYP1B1—digestive system—Crohn's disease	0.00084	0.0113	CbGeAlD
Daunorubicin—Alopecia—Mercaptopurine—Crohn's disease	0.000835	0.00553	CcSEcCtD
Daunorubicin—Deafness—Mesalazine—Crohn's disease	0.000829	0.00549	CcSEcCtD
Daunorubicin—Eye pain—Mesalazine—Crohn's disease	0.000821	0.00544	CcSEcCtD
Daunorubicin—Increased appetite—Mesalazine—Crohn's disease	0.000789	0.00523	CcSEcCtD
Daunorubicin—Atrial fibrillation—Mesalazine—Crohn's disease	0.000782	0.00518	CcSEcCtD
Daunorubicin—CYP1A1—epithelium—Crohn's disease	0.00078	0.0105	CbGeAlD
Daunorubicin—Thirst—Mesalazine—Crohn's disease	0.000779	0.00516	CcSEcCtD
Daunorubicin—Renal impairment—Mesalazine—Crohn's disease	0.000779	0.00516	CcSEcCtD
Daunorubicin—POR—lymph node—Crohn's disease	0.000769	0.0104	CbGeAlD
Daunorubicin—Hepatomegaly—Prednisone—Crohn's disease	0.000764	0.00506	CcSEcCtD
Daunorubicin—Anaemia—Mercaptopurine—Crohn's disease	0.00076	0.00504	CcSEcCtD
Daunorubicin—CYP1A1—skin of body—Crohn's disease	0.000742	0.01	CbGeAlD
Daunorubicin—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000741	0.00491	CcSEcCtD
Daunorubicin—Leukopenia—Mercaptopurine—Crohn's disease	0.000736	0.00488	CcSEcCtD
Daunorubicin—Affect lability—Mesalazine—Crohn's disease	0.00073	0.00483	CcSEcCtD
Daunorubicin—TOP2A—lymph node—Crohn's disease	0.000717	0.00966	CbGeAlD
Daunorubicin—ABCG2—mammalian vulva—Crohn's disease	0.000713	0.00962	CbGeAlD
Daunorubicin—Mood swings—Mesalazine—Crohn's disease	0.000702	0.00465	CcSEcCtD
Daunorubicin—Arthralgia—Mercaptopurine—Crohn's disease	0.0007	0.00464	CcSEcCtD
Daunorubicin—Necrosis—Prednisone—Crohn's disease	0.000689	0.00456	CcSEcCtD
Daunorubicin—Dry skin—Mesalazine—Crohn's disease	0.00068	0.0045	CcSEcCtD
Daunorubicin—CYP1A1—mammalian vulva—Crohn's disease	0.000677	0.00913	CbGeAlD
Daunorubicin—Oedema—Mercaptopurine—Crohn's disease	0.000671	0.00445	CcSEcCtD
Daunorubicin—Pancytopenia—Azathioprine—Crohn's disease	0.000668	0.00442	CcSEcCtD
Daunorubicin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000657	0.00435	CcSEcCtD
Daunorubicin—Gastritis—Mesalazine—Crohn's disease	0.000656	0.00435	CcSEcCtD
Daunorubicin—Dysphagia—Mesalazine—Crohn's disease	0.000641	0.00424	CcSEcCtD
Daunorubicin—Anorexia—Mercaptopurine—Crohn's disease	0.00064	0.00424	CcSEcCtD
Daunorubicin—Angina pectoris—Mesalazine—Crohn's disease	0.000624	0.00413	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000612	0.00405	CcSEcCtD
Daunorubicin—ABCC10—lymph node—Crohn's disease	0.00061	0.00823	CbGeAlD
Daunorubicin—Pancytopenia—Mesalazine—Crohn's disease	0.000609	0.00403	CcSEcCtD
Daunorubicin—CYP1A2—digestive system—Crohn's disease	0.000602	0.00812	CbGeAlD
Daunorubicin—Neutropenia—Mesalazine—Crohn's disease	0.000599	0.00397	CcSEcCtD
Daunorubicin—Dysuria—Mesalazine—Crohn's disease	0.000599	0.00397	CcSEcCtD
Daunorubicin—Viral infection—Prednisone—Crohn's disease	0.000598	0.00396	CcSEcCtD
Daunorubicin—CYP1A1—digestive system—Crohn's disease	0.000594	0.00801	CbGeAlD
Daunorubicin—Decreased appetite—Mercaptopurine—Crohn's disease	0.000584	0.00387	CcSEcCtD
Daunorubicin—CYP3A5—digestive system—Crohn's disease	0.000581	0.00783	CbGeAlD
Daunorubicin—Ulcer—Prednisone—Crohn's disease	0.000571	0.00378	CcSEcCtD
Daunorubicin—Depression—Mesalazine—Crohn's disease	0.00057	0.00377	CcSEcCtD
Daunorubicin—Renal failure—Mesalazine—Crohn's disease	0.000562	0.00372	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00056	0.00371	CcSEcCtD
Daunorubicin—Stomatitis—Mesalazine—Crohn's disease	0.000557	0.00369	CcSEcCtD
Daunorubicin—Conjunctivitis—Mesalazine—Crohn's disease	0.000555	0.00368	CcSEcCtD
Daunorubicin—Hiccups—Prednisone—Crohn's disease	0.00054	0.00358	CcSEcCtD
Daunorubicin—Sinusitis—Mesalazine—Crohn's disease	0.000536	0.00355	CcSEcCtD
Daunorubicin—Body temperature increased—Mercaptopurine—Crohn's disease	0.000531	0.00352	CcSEcCtD
Daunorubicin—Rhinitis—Mesalazine—Crohn's disease	0.000514	0.00341	CcSEcCtD
Daunorubicin—Neuropathy—Prednisone—Crohn's disease	0.000507	0.00336	CcSEcCtD
Daunorubicin—Chills—Azathioprine—Crohn's disease	0.000505	0.00335	CcSEcCtD
Daunorubicin—Arrhythmia—Azathioprine—Crohn's disease	0.000503	0.00333	CcSEcCtD
Daunorubicin—Alopecia—Azathioprine—Crohn's disease	0.000498	0.0033	CcSEcCtD
Daunorubicin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000495	0.00328	CcSEcCtD
Daunorubicin—Oesophagitis—Prednisone—Crohn's disease	0.000494	0.00327	CcSEcCtD
Daunorubicin—ABCC2—lymph node—Crohn's disease	0.00049	0.00661	CbGeAlD
Daunorubicin—CYP1B1—lymph node—Crohn's disease	0.00048	0.00647	CbGeAlD
Daunorubicin—Tinnitus—Mesalazine—Crohn's disease	0.000478	0.00317	CcSEcCtD
Daunorubicin—Cardiac disorder—Mesalazine—Crohn's disease	0.000476	0.00315	CcSEcCtD
Daunorubicin—Hyperkinesia—Prednisone—Crohn's disease	0.000471	0.00312	CcSEcCtD
Daunorubicin—Chills—Mesalazine—Crohn's disease	0.00046	0.00305	CcSEcCtD
Daunorubicin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000459	0.00304	CcSEcCtD
Daunorubicin—Ill-defined disorder—Azathioprine—Crohn's disease	0.000455	0.00301	CcSEcCtD
Daunorubicin—Alopecia—Mesalazine—Crohn's disease	0.000453	0.003	CcSEcCtD
Daunorubicin—Thrombophlebitis—Prednisone—Crohn's disease	0.000453	0.003	CcSEcCtD
Daunorubicin—Anaemia—Azathioprine—Crohn's disease	0.000453	0.003	CcSEcCtD
Daunorubicin—Erythema—Mesalazine—Crohn's disease	0.000447	0.00296	CcSEcCtD
Daunorubicin—Malaise—Azathioprine—Crohn's disease	0.000442	0.00293	CcSEcCtD
Daunorubicin—TOP2A—Methyltestosterone—Prednisone—Crohn's disease	0.000442	0.234	CbGdCrCtD
Daunorubicin—Leukopenia—Azathioprine—Crohn's disease	0.000439	0.00291	CcSEcCtD
Daunorubicin—Dysgeusia—Mesalazine—Crohn's disease	0.000437	0.0029	CcSEcCtD
Daunorubicin—CYP3A4—digestive system—Crohn's disease	0.000436	0.00588	CbGeAlD
Daunorubicin—Cardiac failure congestive—Prednisone—Crohn's disease	0.000433	0.00286	CcSEcCtD
Daunorubicin—Back pain—Mesalazine—Crohn's disease	0.000432	0.00286	CcSEcCtD
Daunorubicin—ABCC1—lymph node—Crohn's disease	0.000432	0.00582	CbGeAlD
Daunorubicin—Vomiting—Mercaptopurine—Crohn's disease	0.000427	0.00283	CcSEcCtD
Daunorubicin—Rash—Mercaptopurine—Crohn's disease	0.000423	0.0028	CcSEcCtD
Daunorubicin—Dermatitis—Mercaptopurine—Crohn's disease	0.000423	0.0028	CcSEcCtD
Daunorubicin—Tremor—Mesalazine—Crohn's disease	0.000418	0.00277	CcSEcCtD
Daunorubicin—Increased appetite—Prednisone—Crohn's disease	0.000418	0.00277	CcSEcCtD
Daunorubicin—Amnesia—Prednisone—Crohn's disease	0.000418	0.00277	CcSEcCtD
Daunorubicin—Arthralgia—Azathioprine—Crohn's disease	0.000417	0.00276	CcSEcCtD
Daunorubicin—Myalgia—Azathioprine—Crohn's disease	0.000417	0.00276	CcSEcCtD
Daunorubicin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000414	0.00274	CcSEcCtD
Daunorubicin—Anaemia—Mesalazine—Crohn's disease	0.000413	0.00273	CcSEcCtD
Daunorubicin—Discomfort—Azathioprine—Crohn's disease	0.000412	0.00273	CcSEcCtD
Daunorubicin—ABCB1—epithelium—Crohn's disease	0.000405	0.00547	CbGeAlD
Daunorubicin—Malaise—Mesalazine—Crohn's disease	0.000403	0.00267	CcSEcCtD
Daunorubicin—Cardiac failure—Prednisone—Crohn's disease	0.000402	0.00266	CcSEcCtD
Daunorubicin—Syncope—Mesalazine—Crohn's disease	0.0004	0.00265	CcSEcCtD
Daunorubicin—Leukopenia—Mesalazine—Crohn's disease	0.0004	0.00265	CcSEcCtD
Daunorubicin—Nausea—Mercaptopurine—Crohn's disease	0.000399	0.00264	CcSEcCtD
Daunorubicin—Infection—Azathioprine—Crohn's disease	0.000397	0.00263	CcSEcCtD
Daunorubicin—Palpitations—Mesalazine—Crohn's disease	0.000395	0.00261	CcSEcCtD
Daunorubicin—Loss of consciousness—Mesalazine—Crohn's disease	0.000392	0.0026	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000392	0.0026	CcSEcCtD
Daunorubicin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000392	0.00259	CcSEcCtD
Daunorubicin—Cough—Mesalazine—Crohn's disease	0.00039	0.00258	CcSEcCtD
Daunorubicin—Affect lability—Prednisone—Crohn's disease	0.000386	0.00256	CcSEcCtD
Daunorubicin—Hypertension—Mesalazine—Crohn's disease	0.000386	0.00255	CcSEcCtD
Daunorubicin—Chest pain—Mesalazine—Crohn's disease	0.00038	0.00252	CcSEcCtD
Daunorubicin—Myalgia—Mesalazine—Crohn's disease	0.00038	0.00252	CcSEcCtD
Daunorubicin—Arthralgia—Mesalazine—Crohn's disease	0.00038	0.00252	CcSEcCtD
Daunorubicin—Anxiety—Mesalazine—Crohn's disease	0.000379	0.00251	CcSEcCtD
Daunorubicin—Discomfort—Mesalazine—Crohn's disease	0.000376	0.00249	CcSEcCtD
Daunorubicin—Cardiac arrest—Prednisone—Crohn's disease	0.000373	0.00247	CcSEcCtD
Daunorubicin—Dry mouth—Mesalazine—Crohn's disease	0.000372	0.00246	CcSEcCtD
Daunorubicin—Mood swings—Prednisone—Crohn's disease	0.000372	0.00246	CcSEcCtD
Daunorubicin—Confusional state—Mesalazine—Crohn's disease	0.000367	0.00243	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000364	0.00241	CcSEcCtD
Daunorubicin—Oedema—Mesalazine—Crohn's disease	0.000364	0.00241	CcSEcCtD
Daunorubicin—Anaphylactic shock—Mesalazine—Crohn's disease	0.000364	0.00241	CcSEcCtD
Daunorubicin—Infection—Mesalazine—Crohn's disease	0.000362	0.0024	CcSEcCtD
Daunorubicin—Dry skin—Prednisone—Crohn's disease	0.00036	0.00238	CcSEcCtD
Daunorubicin—Shock—Mesalazine—Crohn's disease	0.000359	0.00237	CcSEcCtD
Daunorubicin—ABCG2—lymph node—Crohn's disease	0.000357	0.00482	CbGeAlD
Daunorubicin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000357	0.00236	CcSEcCtD
Daunorubicin—Tachycardia—Mesalazine—Crohn's disease	0.000356	0.00236	CcSEcCtD
Daunorubicin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000352	0.00233	CcSEcCtD
Daunorubicin—ABCB1—mammalian vulva—Crohn's disease	0.000352	0.00474	CbGeAlD
Daunorubicin—Anorexia—Mesalazine—Crohn's disease	0.000347	0.0023	CcSEcCtD
Daunorubicin—CYP1A1—lymph node—Crohn's disease	0.000339	0.00457	CbGeAlD
Daunorubicin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000332	0.0022	CcSEcCtD
Daunorubicin—Sweating increased—Prednisone—Crohn's disease	0.00033	0.00219	CcSEcCtD
Daunorubicin—Feeling abnormal—Azathioprine—Crohn's disease	0.00033	0.00218	CcSEcCtD
Daunorubicin—Insomnia—Mesalazine—Crohn's disease	0.00033	0.00218	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000327	0.00217	CcSEcCtD
Daunorubicin—Dyspnoea—Mesalazine—Crohn's disease	0.000325	0.00215	CcSEcCtD
Daunorubicin—Somnolence—Mesalazine—Crohn's disease	0.000324	0.00215	CcSEcCtD
Daunorubicin—Neutropenia—Prednisone—Crohn's disease	0.000317	0.0021	CcSEcCtD
Daunorubicin—Decreased appetite—Mesalazine—Crohn's disease	0.000317	0.0021	CcSEcCtD
Daunorubicin—Abdominal pain—Azathioprine—Crohn's disease	0.000316	0.00209	CcSEcCtD
Daunorubicin—Body temperature increased—Azathioprine—Crohn's disease	0.000316	0.00209	CcSEcCtD
Daunorubicin—Fatigue—Mesalazine—Crohn's disease	0.000314	0.00208	CcSEcCtD
Daunorubicin—ABCB1—lymphoid tissue—Crohn's disease	0.000312	0.00421	CbGeAlD
Daunorubicin—Constipation—Mesalazine—Crohn's disease	0.000312	0.00206	CcSEcCtD
Daunorubicin—Pain—Mesalazine—Crohn's disease	0.000312	0.00206	CcSEcCtD
Daunorubicin—ABCB1—digestive system—Crohn's disease	0.000308	0.00416	CbGeAlD
Daunorubicin—Depression—Prednisone—Crohn's disease	0.000301	0.002	CcSEcCtD
Daunorubicin—Feeling abnormal—Mesalazine—Crohn's disease	0.0003	0.00199	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Prednisone—Crohn's disease	0.000298	0.00197	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000298	0.00197	CcSEcCtD
Daunorubicin—Myocardial infarction—Prednisone—Crohn's disease	0.000296	0.00196	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000296	0.00196	CcSEcCtD
Daunorubicin—Hypersensitivity—Azathioprine—Crohn's disease	0.000295	0.00195	CcSEcCtD
Daunorubicin—Urticaria—Mesalazine—Crohn's disease	0.00029	0.00192	CcSEcCtD
Daunorubicin—Abdominal pain—Mesalazine—Crohn's disease	0.000288	0.00191	CcSEcCtD
Daunorubicin—Body temperature increased—Mesalazine—Crohn's disease	0.000288	0.00191	CcSEcCtD
Daunorubicin—Diarrhoea—Azathioprine—Crohn's disease	0.000274	0.00181	CcSEcCtD
Daunorubicin—Hallucination—Prednisone—Crohn's disease	0.00027	0.00179	CcSEcCtD
Daunorubicin—Hypersensitivity—Mesalazine—Crohn's disease	0.000268	0.00178	CcSEcCtD
Daunorubicin—Dizziness—Azathioprine—Crohn's disease	0.000265	0.00175	CcSEcCtD
Daunorubicin—Asthenia—Mesalazine—Crohn's disease	0.000261	0.00173	CcSEcCtD
Daunorubicin—Pruritus—Mesalazine—Crohn's disease	0.000258	0.00171	CcSEcCtD
Daunorubicin—Vomiting—Azathioprine—Crohn's disease	0.000254	0.00168	CcSEcCtD
Daunorubicin—Rash—Azathioprine—Crohn's disease	0.000252	0.00167	CcSEcCtD
Daunorubicin—Dermatitis—Azathioprine—Crohn's disease	0.000252	0.00167	CcSEcCtD
Daunorubicin—Flushing—Prednisone—Crohn's disease	0.000252	0.00167	CcSEcCtD
Daunorubicin—Headache—Azathioprine—Crohn's disease	0.000251	0.00166	CcSEcCtD
Daunorubicin—Diarrhoea—Mesalazine—Crohn's disease	0.000249	0.00165	CcSEcCtD
Daunorubicin—Arrhythmia—Prednisone—Crohn's disease	0.000242	0.00161	CcSEcCtD
Daunorubicin—Dizziness—Mesalazine—Crohn's disease	0.000241	0.0016	CcSEcCtD
Daunorubicin—Alopecia—Prednisone—Crohn's disease	0.00024	0.00159	CcSEcCtD
Daunorubicin—Nausea—Azathioprine—Crohn's disease	0.000238	0.00157	CcSEcCtD
Daunorubicin—Erythema—Prednisone—Crohn's disease	0.000236	0.00156	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—SMAD3—Crohn's disease	0.000233	0.00541	CbGpPWpGaD
Daunorubicin—Vomiting—Mesalazine—Crohn's disease	0.000232	0.00153	CcSEcCtD
Daunorubicin—ABCB11—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000232	0.00537	CbGpPWpGaD
Daunorubicin—Rash—Mesalazine—Crohn's disease	0.00023	0.00152	CcSEcCtD
Daunorubicin—Dermatitis—Mesalazine—Crohn's disease	0.00023	0.00152	CcSEcCtD
Daunorubicin—Headache—Mesalazine—Crohn's disease	0.000228	0.00151	CcSEcCtD
Daunorubicin—Ill-defined disorder—Prednisone—Crohn's disease	0.000219	0.00145	CcSEcCtD
Daunorubicin—Anaemia—Prednisone—Crohn's disease	0.000218	0.00145	CcSEcCtD
Daunorubicin—Agitation—Prednisone—Crohn's disease	0.000217	0.00144	CcSEcCtD
Daunorubicin—Nausea—Mesalazine—Crohn's disease	0.000216	0.00143	CcSEcCtD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000215	0.00499	CbGpPWpGaD
Daunorubicin—Malaise—Prednisone—Crohn's disease	0.000213	0.00141	CcSEcCtD
Daunorubicin—Syncope—Prednisone—Crohn's disease	0.000212	0.0014	CcSEcCtD
Daunorubicin—Loss of consciousness—Prednisone—Crohn's disease	0.000208	0.00138	CcSEcCtD
Daunorubicin—Convulsion—Prednisone—Crohn's disease	0.000205	0.00136	CcSEcCtD
Daunorubicin—Hypertension—Prednisone—Crohn's disease	0.000204	0.00135	CcSEcCtD
Daunorubicin—Arthralgia—Prednisone—Crohn's disease	0.000201	0.00133	CcSEcCtD
Daunorubicin—Myalgia—Prednisone—Crohn's disease	0.000201	0.00133	CcSEcCtD
Daunorubicin—XDH—Selenium Micronutrient Network—CRP—Crohn's disease	0.0002	0.00465	CbGpPWpGaD
Daunorubicin—Anxiety—Prednisone—Crohn's disease	0.0002	0.00133	CcSEcCtD
Daunorubicin—Discomfort—Prednisone—Crohn's disease	0.000199	0.00132	CcSEcCtD
Daunorubicin—Anaphylactic shock—Prednisone—Crohn's disease	0.000193	0.00128	CcSEcCtD
Daunorubicin—Oedema—Prednisone—Crohn's disease	0.000193	0.00128	CcSEcCtD
Daunorubicin—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000192	0.00445	CbGpPWpGaD
Daunorubicin—Infection—Prednisone—Crohn's disease	0.000192	0.00127	CcSEcCtD
Daunorubicin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00019	0.00442	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00019	0.00442	CbGpPWpGaD
Daunorubicin—Shock—Prednisone—Crohn's disease	0.00019	0.00126	CcSEcCtD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000188	0.00437	CbGpPWpGaD
Daunorubicin—Tachycardia—Prednisone—Crohn's disease	0.000188	0.00125	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisone—Crohn's disease	0.000186	0.00123	CcSEcCtD
Daunorubicin—XDH—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000184	0.00427	CbGpPWpGaD
Daunorubicin—Anorexia—Prednisone—Crohn's disease	0.000184	0.00122	CcSEcCtD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000181	0.00419	CbGpPWpGaD
Daunorubicin—ABCB1—lymph node—Crohn's disease	0.000176	0.00238	CbGeAlD
Daunorubicin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000176	0.00116	CcSEcCtD
Daunorubicin—NR5A1—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000176	0.00407	CbGpPWpGaD
Daunorubicin—Insomnia—Prednisone—Crohn's disease	0.000174	0.00115	CcSEcCtD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.000173	0.004	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—ZFP36L1—Crohn's disease	0.000168	0.00389	CbGpPWpGaD
Daunorubicin—Decreased appetite—Prednisone—Crohn's disease	0.000168	0.00111	CcSEcCtD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000166	0.00386	CbGpPWpGaD
Daunorubicin—Fatigue—Prednisone—Crohn's disease	0.000166	0.0011	CcSEcCtD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000165	0.00383	CbGpPWpGaD
Daunorubicin—Constipation—Prednisone—Crohn's disease	0.000165	0.00109	CcSEcCtD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Crohn's disease	0.000161	0.00373	CbGpPWpGaD
Daunorubicin—CYP1A1—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.00016	0.0037	CbGpPWpGaD
Daunorubicin—Feeling abnormal—Prednisone—Crohn's disease	0.000159	0.00105	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000158	0.00104	CcSEcCtD
Daunorubicin—CYP1B1—Metapathway biotransformation—GPX4—Crohn's disease	0.000155	0.00358	CbGpPWpGaD
Daunorubicin—XDH—Selenium Micronutrient Network—ALB—Crohn's disease	0.000154	0.00356	CbGpPWpGaD
Daunorubicin—Urticaria—Prednisone—Crohn's disease	0.000153	0.00101	CcSEcCtD
Daunorubicin—Abdominal pain—Prednisone—Crohn's disease	0.000152	0.00101	CcSEcCtD
Daunorubicin—Body temperature increased—Prednisone—Crohn's disease	0.000152	0.00101	CcSEcCtD
Daunorubicin—CYP1A1—PPARA activates gene expression—FADS1—Crohn's disease	0.000147	0.00342	CbGpPWpGaD
Daunorubicin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.000144	0.00334	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—DNMT3A—Crohn's disease	0.000143	0.00331	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Prednisone—Crohn's disease	0.000142	0.000941	CcSEcCtD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000141	0.00327	CbGpPWpGaD
Daunorubicin—XDH—Selenium Micronutrient Network—IFNG—Crohn's disease	0.00014	0.00325	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000139	0.00322	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000139	0.00322	CbGpPWpGaD
Daunorubicin—Asthenia—Prednisone—Crohn's disease	0.000138	0.000916	CcSEcCtD
Daunorubicin—Pruritus—Prednisone—Crohn's disease	0.000136	0.000903	CcSEcCtD
Daunorubicin—XDH—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.000134	0.00312	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000133	0.0031	CbGpPWpGaD
Daunorubicin—Diarrhoea—Prednisone—Crohn's disease	0.000132	0.000874	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000131	0.00303	CbGpPWpGaD
Daunorubicin—Dizziness—Prednisone—Crohn's disease	0.000128	0.000844	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000126	0.00293	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000126	0.00291	CbGpPWpGaD
Daunorubicin—XDH—Selenium Micronutrient Network—IL1B—Crohn's disease	0.000125	0.0029	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—JAK2—Crohn's disease	0.000123	0.00286	CbGpPWpGaD
Daunorubicin—Vomiting—Prednisone—Crohn's disease	0.000123	0.000812	CcSEcCtD
Daunorubicin—Rash—Prednisone—Crohn's disease	0.000122	0.000805	CcSEcCtD
Daunorubicin—Dermatitis—Prednisone—Crohn's disease	0.000121	0.000804	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000121	0.00281	CbGpPWpGaD
Daunorubicin—Headache—Prednisone—Crohn's disease	0.000121	0.0008	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—SMAD3—Crohn's disease	0.000118	0.00274	CbGpPWpGaD
Daunorubicin—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000117	0.00271	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000115	0.00267	CbGpPWpGaD
Daunorubicin—Nausea—Prednisone—Crohn's disease	0.000115	0.000758	CcSEcCtD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000113	0.00263	CbGpPWpGaD
Daunorubicin—CYP1B1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000113	0.00263	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000113	0.00261	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000106	0.00246	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—STAT3—Crohn's disease	0.000104	0.00242	CbGpPWpGaD
Daunorubicin—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000102	0.00236	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000101	0.00234	CbGpPWpGaD
Daunorubicin—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000101	0.00234	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.0001	0.00233	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	9.94e-05	0.0023	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	9.79e-05	0.00227	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.7e-05	0.00225	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—HSPA1B—Crohn's disease	9.64e-05	0.00224	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	9.56e-05	0.00222	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—GPX4—Crohn's disease	9.52e-05	0.00221	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	9.44e-05	0.00219	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL12B—Crohn's disease	9.37e-05	0.00217	CbGpPWpGaD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—Crohn's disease	9.1e-05	0.00211	CbGpPWpGaD
Daunorubicin—XDH—Selenium Micronutrient Network—TNF—Crohn's disease	9.08e-05	0.00211	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—Crohn's disease	9.06e-05	0.0021	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—Crohn's disease	9.05e-05	0.0021	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.84e-05	0.00205	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8.65e-05	0.00201	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—UBE2D1—Crohn's disease	8.55e-05	0.00198	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.53e-05	0.00198	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—UBE2D1—Crohn's disease	8.45e-05	0.00196	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.28e-05	0.00192	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.25e-05	0.00191	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.2e-05	0.0019	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.2e-05	0.0019	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	8.17e-05	0.00189	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	8.17e-05	0.00189	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.11e-05	0.00188	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.11e-05	0.00188	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PLA2G4F—Crohn's disease	8.06e-05	0.00187	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	7.77e-05	0.0018	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TYK2—Crohn's disease	7.71e-05	0.00179	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	7.61e-05	0.00177	CbGpPWpGaD
Daunorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	7.51e-05	0.00174	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	7.45e-05	0.00173	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—JAK2—Crohn's disease	7.36e-05	0.00171	CbGpPWpGaD
Daunorubicin—XDH—Selenium Micronutrient Network—IL6—Crohn's disease	7.32e-05	0.0017	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.13e-05	0.00165	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.13e-05	0.00165	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.06e-05	0.00164	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.06e-05	0.00164	CbGpPWpGaD
Daunorubicin—CYP1A1—Arachidonic acid metabolism—PTGS2—Crohn's disease	6.97e-05	0.00162	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	6.93e-05	0.00161	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—MTMR3—Crohn's disease	6.86e-05	0.00159	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—ALB—Crohn's disease	6.85e-05	0.00159	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL10—Crohn's disease	6.85e-05	0.00159	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	6.69e-05	0.00155	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.64e-05	0.00154	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TNF—Crohn's disease	6.6e-05	0.00153	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—TNF—Crohn's disease	6.57e-05	0.00152	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.42e-05	0.00149	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.22e-05	0.00144	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	6.1e-05	0.00142	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	6.07e-05	0.00141	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—SMAD3—Crohn's disease	6.05e-05	0.0014	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.02e-05	0.0014	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—ALB—Crohn's disease	5.99e-05	0.00139	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—UBE2D1—Crohn's disease	5.98e-05	0.00139	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.97e-05	0.00139	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PLA2G4F—Crohn's disease	5.94e-05	0.00138	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5.79e-05	0.00134	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.78e-05	0.00134	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.71e-05	0.00132	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—STAT3—Crohn's disease	5.4e-05	0.00125	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—FADS1—Crohn's disease	5.34e-05	0.00124	CbGpPWpGaD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	5.33e-05	0.00124	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—IL6—Crohn's disease	5.3e-05	0.00123	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.11e-05	0.00118	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.08e-05	0.00118	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—MTMR3—Crohn's disease	5.05e-05	0.00117	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.05e-05	0.00117	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.03e-05	0.00117	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	5.03e-05	0.00117	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.03e-05	0.00117	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GPX4—Crohn's disease	5e-05	0.00116	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.97e-05	0.00115	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	4.96e-05	0.00115	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GCKR—Crohn's disease	4.83e-05	0.00112	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	4.75e-05	0.0011	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	4.68e-05	0.00109	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TNF—Crohn's disease	4.67e-05	0.00108	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RSPO3—Crohn's disease	4.66e-05	0.00108	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PLA2G4F—Crohn's disease	4.47e-05	0.00104	CbGpPWpGaD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.44e-05	0.00103	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.44e-05	0.00103	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	4.42e-05	0.00103	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SEL1L—Crohn's disease	4.42e-05	0.00102	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.4e-05	0.00102	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PLA2G4F—Crohn's disease	4.32e-05	0.001	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.3e-05	0.000998	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	4.03e-05	0.000934	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—LTF—Crohn's disease	3.96e-05	0.000919	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.96e-05	0.000918	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—FADS1—Crohn's disease	3.94e-05	0.000913	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PLA2G4F—Crohn's disease	3.93e-05	0.000911	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.91e-05	0.000906	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	3.89e-05	0.000902	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.86e-05	0.000895	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.86e-05	0.000895	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.81e-05	0.000883	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—MTMR3—Crohn's disease	3.8e-05	0.000881	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—IL6—Crohn's disease	3.77e-05	0.000875	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	3.75e-05	0.000869	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.7e-05	0.000859	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GPX4—Crohn's disease	3.69e-05	0.000855	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—MTMR3—Crohn's disease	3.67e-05	0.000852	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	3.59e-05	0.000833	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GCKR—Crohn's disease	3.56e-05	0.000826	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MTMR3—Crohn's disease	3.34e-05	0.000775	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—MTMR3—Crohn's disease	3.31e-05	0.000767	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.24e-05	0.000751	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.21e-05	0.000744	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	3.21e-05	0.000744	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—GCKR—Crohn's disease	3.19e-05	0.000741	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.12e-05	0.000723	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—IL6—Crohn's disease	3.03e-05	0.000702	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—FADS1—Crohn's disease	2.96e-05	0.000686	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—FADS1—Crohn's disease	2.86e-05	0.000664	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SLC11A1—Crohn's disease	2.82e-05	0.000655	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	2.82e-05	0.000653	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GPX4—Crohn's disease	2.77e-05	0.000642	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.72e-05	0.00063	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GPX4—Crohn's disease	2.68e-05	0.000621	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GCKR—Crohn's disease	2.68e-05	0.000621	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	2.66e-05	0.000617	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—TNF—Crohn's disease	2.61e-05	0.000605	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—FADS1—Crohn's disease	2.6e-05	0.000604	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GCKR—Crohn's disease	2.59e-05	0.0006	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—FADS1—Crohn's disease	2.58e-05	0.000598	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.54e-05	0.00059	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.52e-05	0.000585	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GPX4—Crohn's disease	2.44e-05	0.000565	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RBX1—Crohn's disease	2.42e-05	0.000562	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HSPA1B—Crohn's disease	2.42e-05	0.000562	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GPX4—Crohn's disease	2.41e-05	0.00056	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.4e-05	0.000557	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTMR3—Crohn's disease	2.39e-05	0.000555	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.36e-05	0.000548	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GCKR—Crohn's disease	2.35e-05	0.000546	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GCKR—Crohn's disease	2.33e-05	0.00054	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTMR3—Crohn's disease	2.26e-05	0.000525	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.23e-05	0.000516	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.12e-05	0.000493	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—UBE2D1—Crohn's disease	2.12e-05	0.000492	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.91e-05	0.000443	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.91e-05	0.000442	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—FADS1—Crohn's disease	1.87e-05	0.000433	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.85e-05	0.000429	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.84e-05	0.000427	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.82e-05	0.000422	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTMR3—Crohn's disease	1.81e-05	0.000419	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—FADS1—Crohn's disease	1.76e-05	0.000409	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GPX4—Crohn's disease	1.75e-05	0.000405	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.7e-05	0.000393	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GCKR—Crohn's disease	1.69e-05	0.000391	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.67e-05	0.000388	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GPX4—Crohn's disease	1.65e-05	0.000383	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.62e-05	0.000375	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.6e-05	0.000371	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GCKR—Crohn's disease	1.59e-05	0.00037	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.58e-05	0.000367	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ALB—Crohn's disease	1.54e-05	0.000357	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SMAD3—Crohn's disease	1.52e-05	0.000352	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.44e-05	0.000334	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—FADS1—Crohn's disease	1.41e-05	0.000326	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—Crohn's disease	1.34e-05	0.000312	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GPX4—Crohn's disease	1.32e-05	0.000306	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.31e-05	0.000304	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.29e-05	0.000298	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GCKR—Crohn's disease	1.27e-05	0.000295	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.14e-05	0.000264	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ALB—Crohn's disease	1.13e-05	0.000263	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—FADS1—Crohn's disease	1.12e-05	0.000261	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.11e-05	0.000258	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPX4—Crohn's disease	1.05e-05	0.000244	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GCKR—Crohn's disease	1.02e-05	0.000236	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.96e-06	0.000231	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—Crohn's disease	9.92e-06	0.00023	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TYK2—Crohn's disease	9.91e-06	0.00023	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—JAK2—Crohn's disease	9.45e-06	0.000219	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD4—Crohn's disease	8.96e-06	0.000208	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—Crohn's disease	8.89e-06	0.000206	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—FADS1—Crohn's disease	8.67e-06	0.000201	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	8.65e-06	0.000201	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—Crohn's disease	8.51e-06	0.000197	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—Crohn's disease	8.24e-06	0.000191	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPX4—Crohn's disease	8.12e-06	0.000188	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GCKR—Crohn's disease	7.84e-06	0.000182	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—Crohn's disease	7.49e-06	0.000174	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—Crohn's disease	7.45e-06	0.000173	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—Crohn's disease	7.41e-06	0.000172	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.26e-06	0.000168	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—Crohn's disease	7.2e-06	0.000167	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—Crohn's disease	6.94e-06	0.000161	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—Crohn's disease	6.55e-06	0.000152	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—Crohn's disease	6.49e-06	0.00015	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.35e-06	0.000147	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—Crohn's disease	5.37e-06	0.000125	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—Crohn's disease	5.07e-06	0.000118	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—Crohn's disease	4.85e-06	0.000112	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—Crohn's disease	4.7e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—Crohn's disease	4.44e-06	0.000103	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—Crohn's disease	4.05e-06	9.4e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—Crohn's disease	3.54e-06	8.22e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—Crohn's disease	3.23e-06	7.5e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.83e-06	6.56e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—Crohn's disease	2.5e-06	5.79e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.18e-06	5.06e-05	CbGpPWpGaD
